.webp "The Sanford Guide to Antimicrobial Therapy — 52nd Edition (2022)")
What is the Sanford Guide to Antimicrobial Therapy, 52nd Edition 2022?
The Sanford Guide to Antimicrobial Therapy, 52nd Edition (2022), is a compact clinical reference focused on antimicrobial therapy. It covers antibacterial, antifungal, antimycobacterial, antiparasitic, antiviral, and antiretroviral treatment, along with prophylaxis, drug dosing, interactions, resistance, and special dosing considerations for healthcare professionals.
Introduction
Choosing an appropriate antimicrobial requires more than knowing the name of a drug. Clinicians must consider the suspected or confirmed pathogen, anatomical site of infection, antimicrobial susceptibility, resistance patterns, patient characteristics, drug interactions, organ function, allergies, pregnancy, and other clinical circumstances.
The Sanford Guide to Antimicrobial Therapy, 52nd Edition (2022) is designed as a practical reference for navigating many of these decisions. The 52nd edition was published in 2022 and presents antimicrobial information in a highly structured, rapid-reference format.
The book identifies clinical approaches to initial antimicrobial selection, recommended agents, treatment duration, antimicrobial activity spectra, resistant organisms, pharmacologic information, dosing, adverse effects, and prophylaxis.
The book is particularly relevant to healthcare professionals who routinely evaluate or manage infectious diseases and antimicrobial therapy. Its contents encompass bacterial, fungal, mycobacterial, parasitic, and viral infections, as well as HIV-related therapy and several important prophylactic applications.
Book Overview
Full Book Title
The Sanford Guide to Antimicrobial Therapy
Edition
52nd Edition
Publication Year
2022
Editors
The listed editors are:
- David N. Gilbert, M.D.
- Henry F. Chambers, M.D.
- Michael S. Saag, M.D.
- Andrew T. Pavia, M.D.
- Helen W. Boucher, M.D.
The contributing editors include Douglas Black, Pharm.D., David O. Freedman, M.D., Kami Kim, M.D., and Brian S. Schwartz, M.D.
Publisher
Antimicrobial Therapy, Inc.
Medical Specialty
The primary specialty is infectious diseases and antimicrobial therapy, with extensive material relevant to internal medicine, pediatrics, pharmacy, antimicrobial stewardship, hospital medicine, and other clinical disciplines.
Intended Audience
The organization and breadth of the book make it relevant to medical students, interns, residents, physicians, pharmacists, infectious diseases professionals, and other healthcare practitioners who need a clinical antimicrobial reference.
What This Book Covers
The Sanford Guide to Antimicrobial Therapy 52nd Edition is organized around practical antimicrobial decision-making rather than a conventional narrative textbook format.
Its opening material includes a Clinical Approach to Initial Choice of Antimicrobial Therapy, recommended antimicrobial agents against selected bacteria, suggested treatment durations, and antibacterial, antifungal, and antiviral activity spectra.
A particularly important component is its coverage of antimicrobial resistance. The contents include treatment approaches for multidrug-resistant Gram-positive bacteria, extended-spectrum beta-lactamase-producing Enterobacterales, carbapenem-resistant Enterobacterales, highly resistant Pseudomonas aeruginosa, multidrug-resistant Acinetobacter baumannii complex, and Stenotrophomonas maltophilia.
The book also addresses methicillin-resistant Staphylococcus aureus (MRSA) and provides material concerning antibiotic hypersensitivity and drug desensitization. Pregnancy and lactation safety are included as additional considerations when selecting antimicrobial therapy.
Pharmacology receives substantial attention. The contents include selected pharmacologic characteristics, antibacterial pharmacodynamics, enzyme- and transporter-mediated drug interactions, antibiotic dosage and adverse effects, photosensitivity, aminoglycoside dosing strategies, prolonged or continuous antibiotic infusions, inhaled antibiotics, ECMO dosing adjustments, and QTc prolongation.
Beyond antibacterial therapy, the guide includes dedicated sections for:
- Fungal infections and antifungal drugs
- Mycobacterial infections and antimycobacterial drugs
- Parasitic infections and antiparasitic drugs
- Parasites associated with eosinophilia
- Antiviral therapy
- Non-HIV antiviral drugs
- Antiretroviral therapy for treatment-naive adults with HIV/AIDS
- Antiretroviral adverse effects
- Hepatitis A and hepatitis B treatment
- Hepatitis C treatment regimens and response
The guide also extends into antimicrobial prevention. Its contents include antimicrobial prophylaxis for selected bacterial infections, surgical antibiotic prophylaxis, prevention of bacterial endocarditis in selected patients, management of HIV and hepatitis B/C exposure, and prevention of selected opportunistic infections in transplant recipients.
Special patient populations and dosing considerations are another major component. The book includes pediatric dosing, renal impairment adjustments, antimicrobial dosing in obesity, hepatic disease-related dosage adjustment, and treatment of continuous ambulatory peritoneal dialysis peritonitis.
Key Features
The strongest educational and clinical features of The Sanford Guide to Antimicrobial Therapy 52nd Edition include:
- A rapid-reference approach to initial antimicrobial selection
- Recommended antimicrobial agents for selected bacterial pathogens
- Suggested treatment durations for selected clinical syndromes
- Antibacterial, antifungal, and antiviral activity spectra
- Dedicated information on multidrug-resistant organisms
- MRSA treatment guidance
- Antibiotic hypersensitivity and desensitization information
- Pregnancy and lactation considerations
- Pharmacologic and pharmacodynamic information
- Antimicrobial drug interactions
- Dosing and adverse-effect information
- Special dosing approaches such as prolonged or continuous infusion
- Pediatric antimicrobial dosing
- Renal and hepatic dosing considerations
- Antimicrobial dosing considerations in obesity
- Antimicrobial prophylaxis
- Antifungal, antimycobacterial, antiparasitic, and antiviral therapy
- HIV antiretroviral therapy
- Hepatitis treatment information
- Generic and trade-name listings
Who Should Read This Book?
Medical Students
Medical students studying infectious diseases can use the guide as a concise reference for connecting pathogens, clinical syndromes, antimicrobial classes, and treatment approaches. It is better suited to rapid clinical reference than to replacing a comprehensive narrative infectious diseases textbook.
Interns and Residents
Residents and interns are likely to benefit from the book's practical organization, particularly when antimicrobial selection, dosing, duration, resistance, or special patient considerations need to be reviewed quickly.
The table of contents places initial antimicrobial selection, recommended agents, treatment duration, resistance, pharmacology, and dosing near the beginning of the reference material, which supports rapid navigation.
Specialists
Infectious diseases specialists and other physicians managing complex infections may find the extensive coverage of antimicrobial resistance, pharmacology, drug interactions, and specialized treatment areas useful as a point-of-care reference.
Pharmacists
The pharmacologic sections are particularly relevant to pharmacists. The book includes pharmacodynamics, drug interactions, dosage, adverse effects, prolonged or continuous infusion, aminoglycoside dosing, and organ-function-related dose adjustment.
Why This Book Is Useful
Clinical Relevance
One of the major strengths of the Sanford Guide is its clinical orientation. Instead of presenting antimicrobial agents only as pharmacological entities, the guide organizes information around anatomical sites, diagnoses, modifying circumstances, likely pathogens, suggested regimens, alternatives, and adjunctive diagnostic or therapeutic measures.
For example, its clinical tables distinguish between empiric and pathogen-specific treatment and emphasize reassessment when culture and susceptibility results become available.
Antimicrobial Resistance
Antimicrobial resistance is a major theme in the 52nd edition. Dedicated material addresses ESBL-producing Enterobacterales, carbapenem-resistant Enterobacterales, resistant Pseudomonas aeruginosa, multidrug-resistant Acinetobacter, Stenotrophomonas maltophilia, and MRSA.
The antibacterial activity tables also caution that resistance patterns can vary according to geographical region and clinical setting, including community-onset versus ICU-acquired infection.
Evidence and Clinical References
The book incorporates references to clinical guidelines, systematic reviews, randomized trials, and medical journals throughout its treatment tables. Its pages cite sources such as Clinical Infectious Diseases, New England Journal of Medicine, Lancet, JAMA, and other medical literature. This makes the reference useful for clinicians who want treatment recommendations presented alongside supporting literature.
Learning Efficiency
The rapid-reference format is one of the book's defining characteristics. A page guide in the book directs readers to major sections including initial antimicrobial selection, recommended antibacterial agents, duration of therapy, antimicrobial spectra, resistant bacteria and MRSA, pharmacologic features, antimicrobial dosing, antifungal therapy, antimycobacterial therapy, antiparasitic therapy, antiviral therapy, HIV therapy, HCV treatment, prophylaxis, pediatric dosing, renal adjustments, drug interactions, and generic and trade names.
Table of Contents Overview
The major sections identified in the 52nd edition include:
- Abbreviations
- Clinical approach to initial antimicrobial therapy
- Recommended antibacterial agents
- Duration of antimicrobial therapy
- Antimicrobial activity spectra
- Multidrug-resistant bacteria and MRSA
- Pharmacologic features of antimicrobial agents
- Antibacterial dosage and side effects
- Antifungal therapy
- Antimycobacterial therapy
- Antiparasitic therapy
- Antiviral therapy
- Antiretroviral therapy for HIV
- Hepatitis treatment
- Antimicrobial prophylaxis
- Opportunistic infections in transplant populations
- Pediatric dosing
- Renal impairment adjustments
- Drug-drug interactions
- Generic and trade names
- Index
Strengths of The Book
The primary academic strength of The Sanford Guide to Antimicrobial Therapy 52nd Edition is its breadth combined with a practical reference structure.
Rather than concentrating exclusively on antibacterial drugs, it spans antibacterial, antifungal, antimycobacterial, antiparasitic, antiviral, and antiretroviral therapy. It also incorporates antimicrobial prophylaxis, special populations, pharmacology, interactions, and dose adjustment.
Another strength is its attention to resistant pathogens. The inclusion of dedicated sections for several highly resistant Gram-negative organisms and MRSA makes antimicrobial resistance an integral part of the reference rather than an isolated topic.
The book's tables also provide a useful distinction between recommended, active, variable, and less favorable antimicrobial options in its activity-spectrum material.
Its multidisciplinary editorial team is another notable feature. The listed editors and contributors include physicians from infectious diseases, internal medicine, pediatric infectious diseases, global medicine, and pharmacy backgrounds.
Limitations
A practical limitation is that this is fundamentally a rapid clinical reference, not a conventional comprehensive narrative textbook. Readers seeking extensive pathophysiology, detailed microbiology teaching, or long-form explanations of infectious disease mechanisms may need additional educational resources.
The 2022 edition is also a historical edition rather than the current version of the guide. The book itself states that the guide is updated annually and directs readers toward its web edition and mobile applications for more current information.
Another important limitation is that antimicrobial recommendations cannot be separated from current prescribing information, local resistance patterns, patient-specific factors, and professional judgment.
The book explicitly advises readers to consult current full prescribing information before prescribing and emphasizes that applying the information to an individual patient remains the practitioner's professional responsibility.
Comparison With Similar Books
The Sanford Guide has a particularly strong rapid-reference and treatment-table orientation, with extensive coverage of antimicrobial selection, spectra, dosing, resistance, interactions, prophylaxis, and special populations.
Readers looking for detailed comparisons with other textbooks should evaluate those books independently rather than treating an unsupported comparison as part of this review.
FAQs
The Sanford Guide to Antimicrobial Therapy, 52nd Edition, is a 2022 clinical reference focused on antimicrobial treatment. It covers antibacterial, antifungal, antimycobacterial, antiparasitic, antiviral, and antiretroviral therapy, together with prophylaxis, dosing, interactions, and special clinical considerations.
The book is particularly relevant to healthcare professionals who manage infections or prescribe, monitor, or study antimicrobial therapy. Its multidisciplinary content is also useful for medical students, residents, pharmacists, researchers, and educators.
The book covers antibacterial, antifungal, antimycobacterial, antiparasitic, antiviral, and antiretroviral therapies. It also includes treatment information for hepatitis A, hepatitis B, and hepatitis C.
Yes. The contents include dedicated material addressing multidrug-resistant Gram-positive organisms, ESBL-producing Enterobacterales, carbapenem-resistant Enterobacterales, highly resistant Pseudomonas aeruginosa, multidrug-resistant Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and MRSA.
Yes. Pediatric dosing is included as a dedicated section, along with dosing considerations for renal impairment, obesity, and hepatic disease.
Yes. The contents include enzyme- and transporter-mediated interactions involving antimicrobials as well as a dedicated section on anti-infective drug-drug interactions.
It is structured as a clinical antimicrobial reference and contains extensive treatment and dosing information. However, the book itself emphasizes that current prescribing information should be consulted and that applying recommendations to an individual patient remains the responsibility of the practitioner.
No. The book identifies itself as the 2022 52nd Edition and states that the guide is updated annually. It directs readers to its web edition and mobile applications for the most current information.
Conclusion
The Sanford Guide to Antimicrobial Therapy 52nd Edition is a broad, clinically oriented antimicrobial reference designed around rapid access to treatment information. Its coverage extends well beyond conventional antibacterial therapy to include fungal, mycobacterial, parasitic, viral, and antiretroviral treatment, as well as prophylaxis and specialized dosing considerations.
Its greatest educational value lies in the way it connects clinical syndromes with antimicrobial selection, likely pathogens, resistance considerations, dosing, treatment duration, adverse effects, interactions, and patient-specific factors. The extensive material on resistant organisms and special populations further increases its relevance to contemporary infectious disease practice.
For medical students and residents, the Sanford Guide to Antimicrobial Therapy 52nd Edition can function as a concise antimicrobial reference alongside more comprehensive textbooks. For practicing clinicians and pharmacists, its rapid-reference tables can support review of antimicrobial choices and dosing considerations.
Because this edition was published in 2022 and the guide is updated annually, readers should recognize the edition's date and verify current prescribing information and recommendations before applying antimicrobial therapy to individual patients. The book itself makes this distinction explicitly.
Overall, the 52nd edition represents a substantial reference for understanding and reviewing antimicrobial therapy, particularly when the reader needs organized clinical information rather than a lengthy narrative discussion.